Hepatocellular carcinoma: what are the differential costs compared to the general population?

Abstract

Hepatocellular carcinoma (HCC), which accounts for about 90% of all primary liver can-cer cases, is the fifth most common malignancy and the second leading cause of cancer-related mor-tality worldwide. This study aims to analyse the differential costs of HCC-related hospital admissionscompared to the general population in Spain (...)